G207 Followed by Radiation Therapy in Malignant Glioma

NCT00157703 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma

Interventions

DRUG: G207

Sponsor

MediGene

Collaborators

[object Object]